Literature DB >> 22271370

Heme oxygenase-1 promoter polymorphism is associated with risk of malignant mesothelioma.

Aki Murakami1, Yoshihiro Fujimori, Yoshie Yoshikawa, Shusai Yamada, Kunihiro Tamura, Noriko Hirayama, Takayuki Terada, Kozo Kuribayashi, Chiharu Tabata, Kazuya Fukuoka, Tomoko Tamaoki, Takashi Nakano.   

Abstract

BACKGROUND: Malignant mesothelioma is an aggressive tumor of serosal surfaces that is closely associated with asbestos exposure which induces oxidative stress. Heme oxygenase (HO)-1, a rate-limiting enzyme of heme degradation, plays a protective role against oxidative stress. The HO-1 gene promoter carries (GT)n repeats whose number is inversely related to transcriptional activity of the HO-1 gene.
METHODS: To investigate the relationship between the length polymorphism of (GT)n repeats and mesothelioma susceptibility, we analyzed the HO-1 promoter in 44 asbestos-exposed subjects without mesothelioma and 78 asbestos-exposed subjects with mesothelioma using PCR-based genotyping.
RESULTS: The number of repeats ranged from 16 to 38, with two peaks at 23 and 30 repeats. Polymorphisms of (GT)n repeats were grouped into two classes of alleles, short (S) (<24) and long (L) (≥24), and three genotypes: L/L, L/S, and S/S. The proportions of allele frequencies in class L as well as genotypic frequencies of L allele carriers (L/L and L/S) were significantly higher in the asbestos-exposed subjects with mesothelioma than in those without mesothelioma.
CONCLUSION: The findings of this study suggest that long (GT)n repeats in the HO-1 gene promoter are associated with a higher risk of malignant mesothelioma in the Japanese population.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22271370     DOI: 10.1007/s00408-012-9371-2

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   2.584


  28 in total

1.  Regulation of human heme oxygenase-1 gene expression under thermal stress.

Authors:  S Okinaga; K Takahashi; K Takeda; M Yoshizawa; H Fujita; H Sasaki; S Shibahara
Journal:  Blood       Date:  1996-06-15       Impact factor: 22.113

Review 2.  Malignant pleural mesothelioma.

Authors:  P Baas; H Schouwink; F A Zoetmulder
Journal:  Ann Oncol       Date:  1998-02       Impact factor: 32.976

3.  A review of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. The Fifth Report, 1993.

Authors:  M H Alderman
Journal:  Am J Hypertens       Date:  1993-10       Impact factor: 2.689

4.  Protective effects of heme oxygenase-1 against oxidant-induced injury in the cultured human tracheal epithelium.

Authors:  N Yamada; M Yamaya; S Okinaga; R Lie; T Suzuki; K Nakayama; A Takeda; T Yamaguchi; Y Itoyama; K Sekizawa; H Sasaki
Journal:  Am J Respir Cell Mol Biol       Date:  1999-09       Impact factor: 6.914

5.  Microsatellite polymorphism in heme oxygenase-1 gene promoter is associated with susceptibility to oxidant-induced apoptosis in lymphoblastoid cell lines.

Authors:  Hisao Hirai; Hiroshi Kubo; Mutsuo Yamaya; Katsutoshi Nakayama; Muneo Numasaki; Seiichi Kobayashi; Satoshi Suzuki; Shigeki Shibahara; Hidetada Sasaki
Journal:  Blood       Date:  2003-05-01       Impact factor: 22.113

6.  Arsenic methylation capability, heme oxygenase-1 and NADPH quinone oxidoreductase-1 genetic polymorphisms and the stage and grade of urothelial carcinomas.

Authors:  Steven K Huang; Allen Wen-Hsiang Chiu; Yeong-Shiau Pu; Yung-Kai Huang; Chi-Jung Chung; Hui-Ju Tsai; Mo-Hsiung Yang; Chien-Jen Chen; Yu-Mei Hsueh
Journal:  Urol Int       Date:  2008-06-27       Impact factor: 2.089

7.  Microsatellite polymorphism in promoter of heme oxygenase-1 gene is associated with susceptibility to coronary artery disease in type 2 diabetic patients.

Authors:  Ying-Hwa Chen; Shing-Jong Lin; Ming-Wei Lin; Hui-Ling Tsai; San-San Kuo; Jaw-Wen Chen; Min-Ji Charng; Tao-Cheng Wu; Lung-Ching Chen; Yu-An Ding; Wen-Harn Pan; Yuh-Shan Jou; Lee-Young Chau
Journal:  Hum Genet       Date:  2002-06-19       Impact factor: 4.132

8.  Role of oxygen derivatives in the cytotoxicity and DNA damage produced by asbestos on rat pleural mesothelial cells in vitro.

Authors:  H Dong; A Buard; A Renier; F Lévy; L Saint-Etienne; M C Jaurand
Journal:  Carcinogenesis       Date:  1994-06       Impact factor: 4.944

9.  Ozone, oxidant defense genes, and risk of asthma during adolescence.

Authors:  Talat Islam; Rob McConnell; W James Gauderman; Ed Avol; John M Peters; Frank D Gilliland
Journal:  Am J Respir Crit Care Med       Date:  2007-11-29       Impact factor: 21.405

10.  Oxidant stress responses in human pleural mesothelial cells exposed to asbestos.

Authors:  Y M Janssen; J P Marsh; M P Absher; E Gabrielson; P J Borm; K Driscoll; B T Mossman
Journal:  Am J Respir Crit Care Med       Date:  1994-03       Impact factor: 21.405

View more
  7 in total

Review 1.  Heme oxygenase in neonatal lung injury and repair.

Authors:  Phyllis A Dennery
Journal:  Antioxid Redox Signal       Date:  2014-02-19       Impact factor: 8.401

Review 2.  A review on heme oxygenase-1 induction: is it a necessary evil.

Authors:  Ajaz Ahmad Waza; Zeenat Hamid; Sajad Ali; Shabir Ahmad Bhat; Musadiq Ahmad Bhat
Journal:  Inflamm Res       Date:  2018-04-24       Impact factor: 4.575

Review 3.  Heme oxygenase-1: emerging target of cancer therapy.

Authors:  Lee-Young Chau
Journal:  J Biomed Sci       Date:  2015-03-21       Impact factor: 8.410

4.  Microsatellite polymorphism in the Heme oxygenase-1 gene promoter is associated with dermal collagen density in Japanese obese male subjects.

Authors:  Ai Ibuki; Takeo Minematsu; Mikako Yoshida; Shinji Iizaka; Masaru Matsumoto; Junko Sugama; Hiromi Sanada
Journal:  PLoS One       Date:  2018-07-19       Impact factor: 3.240

5.  Association between heme oxygenase-1 gene promoter polymorphisms and cancer susceptibility: A meta-analysis.

Authors:  Rui Wang; Jun Shen; Rui Yang; Wan-Guo Wang; Ye Yuan; Zhong-Hua Guo
Journal:  Biomed Rep       Date:  2018-01-25

6.  Role of HMOX1 Promoter Genetic Variants in Chemoresistance and Chemotherapy Induced Neutropenia in Children with Acute Lymphoblastic Leukemia.

Authors:  Karolina Bukowska-Strakova; Joanna Włodek; Ewelina Pitera; Magdalena Kozakowska; Anna Konturek-Cieśla; Maciej Cieśla; Monika Gońka; Witold Nowak; Aleksandra Wieczorek; Katarzyna Pawińska-Wąsikowska; Alicja Józkowicz; Maciej Siedlar
Journal:  Int J Mol Sci       Date:  2021-01-20       Impact factor: 5.923

Review 7.  Clinical Significance of Heme Oxygenase 1 in Tumor Progression.

Authors:  Mariapaola Nitti; Caterina Ivaldo; Nicola Traverso; Anna Lisa Furfaro
Journal:  Antioxidants (Basel)       Date:  2021-05-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.